So Hyun Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
So Hyun Kang has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Sang-Hoon Ahn
Department of Surgery, Samsung Medical Center, Seoul, Republic of Korea
22 shared publications - Young Suk Park
Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
16 shared publications - Hyung-Ho Kim
Department of Surgery, Chung-Ang University Gwangmyeong Hospital, 110 Deokan-ro, Gwangmyeong-si, Gyeonggi-do, Korea.
15 shared publications - Yun-Suhk Suh
Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
13 shared publications - Do Joong Park
Department of Surgery, Seoul National University Hospital, Seoul, Korea
11 shared publications - Eunju Lee
Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
9 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Gastric Cancer
- Vol. 26 (3) , 433-447
Impact of Combined Frailty and Sarcopenia on Postoperative Outcomes and Survival in Elderly Gastric Cancer Patients Undergoing Gastrectomy
Frailty and sarcopenia are associated with adverse postoperative outcomes in elderly patients undergoing gastrectomy for gastric cancer. However, large-scale evidence remains limited. This study aimed to investigate the associations of frailty and sarcopenia with postoperative outcomes and long-term survival in this population. This retrospective study included patients aged ≥70 years who underwent gastrectomy for gastric cancer between December 2011 and May 2021 and had preoperative comprehensive geriatric assessment and abdominal computed tomography. Frailty was defined as a multidimensional frailty score >6, and sarcopenia was defined as the L3 skeletal muscle index in the lowest tertile for each sex. The patients were categorized as non-frail/non-sarcopenic (NF/NS), frail or sarcopenic (F or S), or frail and sarcopenic (F/S). A total of 508 patients (mean age, 77.6±4.6 years; 64.0% male) were analyzed. Eighty-two patients (16.1%) experienced Clavien-Dindo grade ≥II complications within 30 days. In multivariable logistic regression analysis, the F/S group was an independent predictor of postoperative complications (odds ratio, 2.73; 95% confidence interval [CI], 1.07-6.98; P=0.036). In multivariable Cox regression analysis, both the F or S and F/S groups showed significantly worse overall survival (hazard ratio [HR], 2.17 and 3.11, respectively; both P<0.001). The F/S group showed significantly worse cancer-specific survival (HR, 2.46; 95% CI, 1.02-5.93; P=0.046). Combined frailty and sarcopenia were independently associated with worse postoperative outcomes and survival in elderly patients with gastric cancer. Either condition alone was also associated with worse overall survival, suggesting a dose-response relationship and highlighting the importance of comprehensive geriatric assessment.
- 1 January 2026
- Published by XMLink in Journal of Gastric Cancer
- Vol. 26 (3) , 433-447
Open AccessImpact of Combined Frailty and Sarcopenia on Postoperative Outcomes and Survival in Elderly Gastric Cancer Patients Undergoing Gastrectomy
Frailty and sarcopenia are associated with adverse postoperative outcomes in elderly patients undergoing gastrectomy for gastric cancer. However, large-scale evidence remains limited. This study aimed to investigate the associations of frailty and sarcopenia with postoperative outcomes and long-term survival in this population. This retrospective study included patients aged ≥70 years who underwent gastrectomy for gastric cancer between December 2011 and May 2021 and had preoperative comprehensive geriatric assessment and abdominal computed tomography. Frailty was defined as a multidimensional frailty score >6, and sarcopenia was defined as the L3 skeletal muscle index in the lowest tertile for each sex. The patients were categorized as non-frail/non-sarcopenic (NF/NS), frail or sarcopenic (F or S), or frail and sarcopenic (F/S). A total of 508 patients (mean age, 77.6±4.6 years; 64.0% male) were analyzed. Eighty-two patients (16.1%) experienced Clavien-Dindo grade ≥II complications within 30 days. In multivariable logistic regression analysis, the F/S group was an independent predictor of postoperative complications (odds ratio, 2.73; 95% confidence interval [CI], 1.07-6.98; P=0.036). In multivariable Cox regression analysis, both the F or S and F/S groups showed significantly worse overall survival (hazard ratio [HR], 2.17 and 3.11, respectively; both P<0.001). The F/S group showed significantly worse cancer-specific survival (HR, 2.46; 95% CI, 1.02-5.93; P=0.046). Combined frailty and sarcopenia were independently associated with worse postoperative outcomes and survival in elderly patients with gastric cancer. Either condition alone was also associated with worse overall survival, suggesting a dose-response relationship and highlighting the importance of comprehensive geriatric assessment.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Metabolic and Bariatric Surgery
- Vol. 15 (1) , 20-27
Beyond the Procedure: Revisiting the Technical Determinants of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass
Metabolic and bariatric surgery has become an increasingly technique-sensitive field in which even modest intraoperative variations may influence postoperative physiology and long-term outcomes. Although sleeve gastrectomy and Roux-en-Y gastric bypass are well-established procedures, substantial heterogeneity persists in how key technical steps are performed. This review revisits several high-impact technical determinants that remain clinically relevant in routine practice, focusing on antral preservation and bougie calibration in sleeve gastrectomy, and pouch size and gastrojejunostomy (GJ) stoma diameter in Roux-en-Y gastric bypass. In sleeve gastrectomy, more aggressive antral resection and smaller bougie calibers may confer a modest short-term weight-loss advantage, but these benefits appear to be offset by trade-offs involving reflux, stricture, and postoperative intolerance. In Roux-en-Y gastric bypass, smaller gastric pouches and avoidance of an excessively wide GJ are generally associated with more favorable weight-loss outcomes, although reproducibility of construction may be more important than any single numeric target. Overall, current evidence does not support one universally ideal technical configuration. Rather, it supports a balanced strategy based on standardized, reproducible baseline technique, avoidance of extremes, and selective personalization according to patient phenotype, risk profile, and treatment goals.
- 1 January 2026
- Published by XMLink in Journal of Metabolic and Bariatric Surgery
- Vol. 15 (1) , 20-27
Open AccessBeyond the Procedure: Revisiting the Technical Determinants of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass
Metabolic and bariatric surgery has become an increasingly technique-sensitive field in which even modest intraoperative variations may influence postoperative physiology and long-term outcomes. Although sleeve gastrectomy and Roux-en-Y gastric bypass are well-established procedures, substantial heterogeneity persists in how key technical steps are performed. This review revisits several high-impact technical determinants that remain clinically relevant in routine practice, focusing on antral preservation and bougie calibration in sleeve gastrectomy, and pouch size and gastrojejunostomy (GJ) stoma diameter in Roux-en-Y gastric bypass. In sleeve gastrectomy, more aggressive antral resection and smaller bougie calibers may confer a modest short-term weight-loss advantage, but these benefits appear to be offset by trade-offs involving reflux, stricture, and postoperative intolerance. In Roux-en-Y gastric bypass, smaller gastric pouches and avoidance of an excessively wide GJ are generally associated with more favorable weight-loss outcomes, although reproducibility of construction may be more important than any single numeric target. Overall, current evidence does not support one universally ideal technical configuration. Rather, it supports a balanced strategy based on standardized, reproducible baseline technique, avoidance of extremes, and selective personalization according to patient phenotype, risk profile, and treatment goals.
- 11 March 2025
- Published by Wiley in World Journal of Surgery
- Vol. 49 (4) , 1110-1114
Reduced‐Ports Robotic Pylorus‐Preserving Gastrectomy for Gastric Cancer
Background: Laparoscopic gastrectomy has proven to be safe and effective as a first‐line treatment for early gastric cancer in terms of oncologic results. The da Vinci robotic system offers stable 3D vision, near‐infrared fluorescence imaging, and articulating wrist movements, making it suitable for performing reduced‐ports robotic pylorus‐preserving gastrectomy (RP‐RPPG). This study examines the feasibility and safety of RP‐RPPG for gastric cancer.Methods: Patients who underwent RP‐RPPG at a single institution from March 2019 to October 2023 were enrolled. Electronic medical records were retrospectively reviewed for operative time, estimated blood loss (EBL), retrieved number of lymph nodes, postoperative hospital course, and early complications. Learning curve using operation time was analyzed through cumulative sum (CUSUM) and segmental analysis methods.Results: Among the 79 patients included, the median operation time was 175.0 (66.0) minutes, and estimated blood loss was 10.0 (25.0) mL. Early complications occurred in 6 patients (7.6%), but all were managed conservatively without needing invasive intervention. Among them, delayed gastric emptying was observed in 3 patients (3.8%). The learning curve analysis indicated a proficiency threshold after the 38th procedure, aligning with a subsequent decrease in operative times as the surgeon’s experience progressed.Conclusion: RP‐RPPG is feasible and can be performed safely by an experienced surgeon without increasing early postoperative morbidity.
- 11 March 2025
- Published by Wiley in World Journal of Surgery
- Vol. 49 (4) , 1110-1114
Reduced‐Ports Robotic Pylorus‐Preserving Gastrectomy for Gastric Cancer
Background: Laparoscopic gastrectomy has proven to be safe and effective as a first‐line treatment for early gastric cancer in terms of oncologic results. The da Vinci robotic system offers stable 3D vision, near‐infrared fluorescence imaging, and articulating wrist movements, making it suitable for performing reduced‐ports robotic pylorus‐preserving gastrectomy (RP‐RPPG). This study examines the feasibility and safety of RP‐RPPG for gastric cancer.Methods: Patients who underwent RP‐RPPG at a single institution from March 2019 to October 2023 were enrolled. Electronic medical records were retrospectively reviewed for operative time, estimated blood loss (EBL), retrieved number of lymph nodes, postoperative hospital course, and early complications. Learning curve using operation time was analyzed through cumulative sum (CUSUM) and segmental analysis methods.Results: Among the 79 patients included, the median operation time was 175.0 (66.0) minutes, and estimated blood loss was 10.0 (25.0) mL. Early complications occurred in 6 patients (7.6%), but all were managed conservatively without needing invasive intervention. Among them, delayed gastric emptying was observed in 3 patients (3.8%). The learning curve analysis indicated a proficiency threshold after the 38th procedure, aligning with a subsequent decrease in operative times as the surgeon’s experience progressed.Conclusion: RP‐RPPG is feasible and can be performed safely by an experienced surgeon without increasing early postoperative morbidity.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Gastric Cancer
- Vol. 25 (2) , 382-399
Prospective Multicenter Observational Study on Postoperative Quality of Life According to Type of Gastrectomy for Gastric Cancer
Oh SE, et al. J Gastric Cancer. 2025 Apr;25(2):382-399. https://doi.org/10.5230/jgc.2025.25.e26
- 1 January 2025
- Published by XMLink in Journal of Gastric Cancer
- Vol. 25 (2) , 382-399
Open AccessProspective Multicenter Observational Study on Postoperative Quality of Life According to Type of Gastrectomy for Gastric Cancer
Oh SE, et al. J Gastric Cancer. 2025 Apr;25(2):382-399. https://doi.org/10.5230/jgc.2025.25.e26
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Gastric Cancer
- Vol. 25 (2) , 330-342
Comparison of Reduced Port Gastrectomy and Multiport Gastrectomy in Korea: Ad Hoc Analysis and Nationwide Survey on Gastric Cancer 2019
Hwang D, et al. J Gastric Cancer. 2025 Feb;25:e15. https://doi.org/10.5230/jgc.2025.25.e15
- 1 January 2025
- Published by XMLink in Journal of Gastric Cancer
- Vol. 25 (2) , 330-342
Open AccessComparison of Reduced Port Gastrectomy and Multiport Gastrectomy in Korea: Ad Hoc Analysis and Nationwide Survey on Gastric Cancer 2019
Hwang D, et al. J Gastric Cancer. 2025 Feb;25:e15. https://doi.org/10.5230/jgc.2025.25.e15
- Open Access
- 1 January 2024
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 107 (4) , 229-236
A prospective randomized trial comparing the efficacy of temperature-responsive gel with local anesthetics versus local anesthetic infusion pump device for postoperative pain control after bariatric surgery
Yoo M, et al. Ann Surg Treat Res. 2024 Oct;107(4):229-236. https://doi.org/10.4174/astr.2024.107.4.229
- 1 January 2024
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 107 (4) , 229-236
Open AccessA prospective randomized trial comparing the efficacy of temperature-responsive gel with local anesthetics versus local anesthetic infusion pump device for postoperative pain control after bariatric surgery
Yoo M, et al. Ann Surg Treat Res. 2024 Oct;107(4):229-236. https://doi.org/10.4174/astr.2024.107.4.229
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Gastric Cancer
- Vol. 24 (3) , 246-256
Efficacy of Hyperthermic Pressurized Intraperitoneal Aerosol Chemotherapy in an In Vitro Model Using a Human Gastric Cancer AGS Cell Line and an Abdominal Cavity Model
Min SH, et al. J Gastric Cancer. 2024 Jun;24:e24. https://doi.org/10.5230/jgc.2024.24.e24
- 1 January 2024
- Published by XMLink in Journal of Gastric Cancer
- Vol. 24 (3) , 246-256
Open AccessEfficacy of Hyperthermic Pressurized Intraperitoneal Aerosol Chemotherapy in an In Vitro Model Using a Human Gastric Cancer AGS Cell Line and an Abdominal Cavity Model
Min SH, et al. J Gastric Cancer. 2024 Jun;24:e24. https://doi.org/10.5230/jgc.2024.24.e24
- Open Access
- 15 March 2023
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 18 (2) , 231-244
Analysis of Characteristics and Risk Factors of Patients with Single Gastric Cancer and Synchronous Multiple Gastric Cancer among 14,603 Patients
Du Hyun Song, Nayoung Kim, Hyeong Ho Jo, Sangbin Kim, Yonghoon Choi, Hyeon Jeong Oh, Hye Seung Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, So Hyun Kang, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim, Soyeon Ahn, Young-Joon Surh. Gut and Liver 2024;18:231-44. https://doi.org/10.5009/gnl220491
- 15 March 2023
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 18 (2) , 231-244
Open AccessAnalysis of Characteristics and Risk Factors of Patients with Single Gastric Cancer and Synchronous Multiple Gastric Cancer among 14,603 Patients
Du Hyun Song, Nayoung Kim, Hyeong Ho Jo, Sangbin Kim, Yonghoon Choi, Hyeon Jeong Oh, Hye Seung Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, So Hyun Kang, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim, Soyeon Ahn, Young-Joon Surh. Gut and Liver 2024;18:231-44. https://doi.org/10.5009/gnl220491
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Gastric Cancer
- Vol. 23 (4) , 549-560
The Shorr Versus Modified Ultrafast Papanicolaou Method for Intraoperative Diagnosis of Peritoneal Washing Cytology in Advanced Gastric Cancer: A Phase II Study
Kang SH, et al. J Gastric Cancer. 2023 Oct;23:e34. https://doi.org/10.5230/jgc.2023.23.e34
- 1 January 2023
- Published by XMLink in Journal of Gastric Cancer
- Vol. 23 (4) , 549-560
Open AccessThe Shorr Versus Modified Ultrafast Papanicolaou Method for Intraoperative Diagnosis of Peritoneal Washing Cytology in Advanced Gastric Cancer: A Phase II Study
Kang SH, et al. J Gastric Cancer. 2023 Oct;23:e34. https://doi.org/10.5230/jgc.2023.23.e34
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Robotic and Innovative Surgery
- Vol. 4 (1) , 17-20
Reduced-Ports Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection for Advanced Gastric Cancer Using Articulating Laparoscopic Instruments
Kang SH, et al. Ann Robot Innov Surg. 2023 May;4(1):17-20. https://doi.org/10.37007/aris.2023.4.1.17
- 1 January 2023
- Published by XMLink in Annals of Robotic and Innovative Surgery
- Vol. 4 (1) , 17-20
Open AccessReduced-Ports Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection for Advanced Gastric Cancer Using Articulating Laparoscopic Instruments
Kang SH, et al. Ann Robot Innov Surg. 2023 May;4(1):17-20. https://doi.org/10.37007/aris.2023.4.1.17